Cargando…

Update on host-pathogen interactions in cystic fibrosis lung disease

Bacterial and fungal infections are hallmarks of cystic fibrosis (CF) lung disease. In the era of long-term inhaled antibiotics and increasing CF patient survival, new “emerging” pathogens are detected in CF airways, yet their pathophysiological disease relevance remains largely controversial and in...

Descripción completa

Detalles Bibliográficos
Autores principales: Hector, Andreas, Frey, Nina, Hartl, Dominik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4764602/
https://www.ncbi.nlm.nih.gov/pubmed/26905568
http://dx.doi.org/10.1186/s40348-016-0039-5
_version_ 1782417400793137152
author Hector, Andreas
Frey, Nina
Hartl, Dominik
author_facet Hector, Andreas
Frey, Nina
Hartl, Dominik
author_sort Hector, Andreas
collection PubMed
description Bacterial and fungal infections are hallmarks of cystic fibrosis (CF) lung disease. In the era of long-term inhaled antibiotics and increasing CF patient survival, new “emerging” pathogens are detected in CF airways, yet their pathophysiological disease relevance remains largely controversial and incompletely defined. As a response to chronic microbial triggers, innate immune cells, particularly neutrophils, are continuously recruited into CF airways where they combat pathogens but also cause tissue injury through release of oxidants and proteases. The coordinated interplay between host immune cell activation and pathogens is essential for the outcome of CF lung disease. Here, we provide a concise overview and update on host-pathogen interactions in CF lung disease.
format Online
Article
Text
id pubmed-4764602
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-47646022016-03-29 Update on host-pathogen interactions in cystic fibrosis lung disease Hector, Andreas Frey, Nina Hartl, Dominik Mol Cell Pediatr Mini Review Bacterial and fungal infections are hallmarks of cystic fibrosis (CF) lung disease. In the era of long-term inhaled antibiotics and increasing CF patient survival, new “emerging” pathogens are detected in CF airways, yet their pathophysiological disease relevance remains largely controversial and incompletely defined. As a response to chronic microbial triggers, innate immune cells, particularly neutrophils, are continuously recruited into CF airways where they combat pathogens but also cause tissue injury through release of oxidants and proteases. The coordinated interplay between host immune cell activation and pathogens is essential for the outcome of CF lung disease. Here, we provide a concise overview and update on host-pathogen interactions in CF lung disease. Springer Berlin Heidelberg 2016-02-23 /pmc/articles/PMC4764602/ /pubmed/26905568 http://dx.doi.org/10.1186/s40348-016-0039-5 Text en © Hector et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Mini Review
Hector, Andreas
Frey, Nina
Hartl, Dominik
Update on host-pathogen interactions in cystic fibrosis lung disease
title Update on host-pathogen interactions in cystic fibrosis lung disease
title_full Update on host-pathogen interactions in cystic fibrosis lung disease
title_fullStr Update on host-pathogen interactions in cystic fibrosis lung disease
title_full_unstemmed Update on host-pathogen interactions in cystic fibrosis lung disease
title_short Update on host-pathogen interactions in cystic fibrosis lung disease
title_sort update on host-pathogen interactions in cystic fibrosis lung disease
topic Mini Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4764602/
https://www.ncbi.nlm.nih.gov/pubmed/26905568
http://dx.doi.org/10.1186/s40348-016-0039-5
work_keys_str_mv AT hectorandreas updateonhostpathogeninteractionsincysticfibrosislungdisease
AT freynina updateonhostpathogeninteractionsincysticfibrosislungdisease
AT hartldominik updateonhostpathogeninteractionsincysticfibrosislungdisease